Evonik Reports Q3 2026 Results and Increases Full-Year Outlook

Evonik Industries reported Q3 2026 adjusted EBITDA of €629 million, up 40% from €509 million a year earlier, supported by higher prices and sales volumes. It posted a net loss of €53 million, mainly due to a €313 million provision for additional efficiency-program measures. Management reaffirmed Evonik’s independence and rejected potential takeover interest from BASF, saying restructuring is expected to make its portfolio more attractive.